Overexpression of miR-210, a downstream target of HIF1α, causes centrosome amplification in renal carcinoma cells.
about
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid BiopsiesEpigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathologyHypoxamiRs and cancer: from biology to targeted therapyOxymiRs in cutaneous development, wound repair and regenerationNoncoding RNA Profiles in Tobacco- and Alcohol-Associated DiseasesMultiple functions of hypoxia-regulated miR-210 in cancer.High-throughput sequencing of microRNAs in peripheral blood mononuclear cells: identification of potential weight loss biomarkers.MiR-210 expression reverses radioresistance of stem-like cells of oesophageal squamous cell carcinoma.Epigenetic programming of hypoxic-ischemic encephalopathy in response to fetal hypoxia.Elevated expression of miR-210 predicts poor survival of cancer patients: a systematic review and meta-analysis.Genetic variants in microRNA machinery genes are associated [corrected] with idiopathic recurrent pregnancy loss risk.Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells.A clinical overview of centrosome amplification in human cancers.miR-210: fine-tuning the hypoxic response.Sexual dimorphism in miR-210 expression and mitochondrial dysfunction in the placenta with maternal obesity.MIR-210 modulates mitochondrial respiration in placenta with preeclampsia.miR-125b promotes cell death by targeting spindle assembly checkpoint gene MAD1 and modulating mitotic progressionElevation of Circulating miR-210-3p in High-Altitude Hypoxic Environment.MiR-210 disturbs mitotic progression through regulating a group of mitosis-related genesmiR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis.Reactive oxygen species-responsive miR-210 regulates proliferation and migration of adipose-derived stem cells via PTPN2The regulation and function of microRNAs in kidney diseases.MicroRNA-210 induces apoptosis in colorectal cancer via induction of reactive oxygen.Analysis of MicroRNAs in sputum to improve computed tomography for lung cancer diagnosis.miR-210: the master hypoxamir.miR-210: a therapeutic target in cancer.Tumor hypoxia as a driving force in genetic instability.Emerging roles of miR-210 and other non-coding RNAs in the hypoxic response.Biomarkers in renal cancer.An emerging understanding of long noncoding RNAs in kidney cancer.MicroRNAs in renal cell carcinoma: a systematic review of clinical implications (Review).The role of hypoxia-induced miR-210 in cancer progression.Aberrantly expressed microRNAs in bladder cancer and renal cell carcinoma.MicroRNA-210 and its theranostic potential.WSS25 inhibits Dicer, downregulating microRNA-210, which targets Ephrin-A3, to suppress human microvascular endothelial cell (HMEC-1) tube formation.Prognostic value of meta-signature miRNAs in renal cell carcinoma: an integrated miRNA expression profiling analysisAn integrated analysis of differential miRNA and mRNA expressions in human gallstones.Analysis of long non-coding RNA expression profiles in clear cell renal cell carcinoma.MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients.MiR-210 is induced by Oct-2, regulates B cells, and inhibits autoantibody production.
P2860
Q26748881-81FF3716-9F5C-4D74-8B81-360C3E4EB607Q26752925-154F3844-403B-42D6-B99C-2AAC108F13D2Q26863298-560FA0D1-0CA0-4D2B-BFC4-52138742F8EFQ27024906-96254548-184D-4DDC-B72C-E7549E409390Q28079874-89B3A353-8269-41BE-A954-1E171ED7EA3BQ33765128-2D6AC50C-30A4-41DD-BC8B-09EBD5606B48Q34555861-EA89E897-7DBA-43C2-9211-98A50B96630DQ34657610-0EE38EAC-FF62-4D10-9354-9F9124B09A3FQ34747263-0A20D22D-F6F7-40A8-B9BA-A17AFF25CD15Q35106877-DE6E18CC-033E-41BC-98B6-F646EF740839Q35158159-4D9ABE53-27D3-4178-844E-A052339FEC22Q35301892-9F032081-D2D3-4136-B2F5-EF2F88BEC98EQ35479894-0F775AC9-F5E5-4AAD-9516-5942049B191AQ35891149-0DEE1260-A29C-4EBB-81F6-B69BF5FBCABFQ35920799-68D4097C-1839-4990-98D4-F2AE69B25020Q36227343-A242C7BD-20C3-446A-8FA2-70CBA29564DCQ36609152-78EB3CCB-E967-46F0-95D1-99D445392EBBQ36661001-C5FB06B9-DD37-42F2-BCE9-2FCBBD883719Q36668837-527A040D-F323-41BE-A116-684C8EA2C99CQ36746769-6CEFFE6D-BAD8-4855-83A7-BEAA0D01F398Q36809534-0F062EFB-BF44-4111-B14F-DE66076A8149Q36960910-CDFD50F1-B31C-40DE-8ECE-631BC893A1E6Q36991225-A3FDD57F-5DDB-4332-88BB-E2CC36C8EC11Q37140289-33D949D3-9581-49DF-959F-97D45941AC4EQ37968614-2B3133BE-14AA-48B1-947E-331718871EDAQ38061691-B2D07437-8069-4B29-84C1-1AD95EEC167AQ38155002-81E3D8DC-538D-405B-923D-C9B7B38C139DQ38176255-9B79BAFE-391F-4EF2-A35A-80CDAC475D20Q38184386-AB6A8450-B5BE-4ABE-A471-F9B83121710CQ38210909-D42665C8-E627-4669-9EB3-55AB2D4864C1Q38356005-B72EA2CF-7FA1-413E-82C1-AE1C1485769DQ38391282-F9F32966-C7E0-459B-A42A-2AC98771BB5EQ38881055-155E0248-EFB3-46D6-BC0D-E52F78CDEF50Q38881607-41BBD9FF-73B7-4FD7-8769-ABFFF5C5213BQ39209796-86395F74-EB9C-4F20-AA5E-B96022DF26ABQ40652931-5C3FC7C1-EA36-466F-9A7A-6B76CD1D1256Q41499011-CF41CFBD-06CE-4693-8654-F756252224B6Q41611254-09030E12-8907-4D76-B87F-AECABBCA56DAQ42317002-0B9426CD-C6D6-43C1-AAB5-8CCDFB7CD420Q42874375-2644E7C0-E969-4B08-8BC4-255BCDBE9954
P2860
Overexpression of miR-210, a downstream target of HIF1α, causes centrosome amplification in renal carcinoma cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Overexpression of miR-210, a d ...... tion in renal carcinoma cells.
@en
Overexpression of miR-210, a d ...... tion in renal carcinoma cells.
@nl
type
label
Overexpression of miR-210, a d ...... tion in renal carcinoma cells.
@en
Overexpression of miR-210, a d ...... tion in renal carcinoma cells.
@nl
prefLabel
Overexpression of miR-210, a d ...... tion in renal carcinoma cells.
@en
Overexpression of miR-210, a d ...... tion in renal carcinoma cells.
@nl
P2093
P2860
P356
P1476
Overexpression of miR-210, a d ...... tion in renal carcinoma cells.
@en
P2093
Chisato Nakada
Fuminori Sato
Hiromitsu Mimata
Keiko Matsuura
Masao Seto
Masatsugu Moriyama
Naoki Hijiya
Tomohisa Uchida
Tung Lam Nguyen
Yoshiyuki Tsukamoto
P2860
P304
P356
10.1002/PATH.2860
P577
2011-04-04T00:00:00Z